Exact Mass: 319.1788

Exact Mass Matches: 319.1788

Found 97 metabolites which its exact mass value is equals to given mass value 319.1788, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Chloroquine

N(4)-(7-Chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine

C18H26ClN3 (319.1815)


Chloroquine is only found in individuals that have used or taken this drug. It is a prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. [PubChem]The mechanism of plasmodicidal action of chloroquine is not completely certain. Like other quinoline derivatives, it is thought to inhibit heme polymerase activity. This results in accumulation of free heme, which is toxic to the parasites. nside red blood cells, the malarial parasite must degrade hemoglobin to acquire essential amino acids, which the parasite requires to construct its own protein and for energy metabolism. Digestion is carried out in a vacuole of the parasite cell.During this process, the parasite produces the toxic and soluble molecule heme. The heme moiety consists of a porphyrin ring called Fe(II)-protoporphyrin IX (FP). To avoid destruction by this molecule, the parasite biocrystallizes heme to form hemozoin, a non-toxic molecule. Hemozoin collects in the digestive vacuole as insoluble crystals.Chloroquine enters the red blood cell, inhabiting parasite cell, and digestive vacuole by simple diffusion. Chloroquine then becomes protonated (to CQ2+), as the digestive vacuole is known to be acidic (pH 4.7); chloroquine then cannot leave by diffusion. Chloroquine caps hemozoin molecules to prevent further biocrystallization of heme, thus leading to heme buildup. Chloroquine binds to heme (or FP) to form what is known as the FP-Chloroquine complex; this complex is highly toxic to the cell and disrupts membrane function. Action of the toxic FP-Chloroquine and FP results in cell lysis and ultimately parasite cell autodigestion. In essence, the parasite cell drowns in its own metabolic products. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   

2-[2-[[4-[[3-Aminopropyl]amino]butyl]amino]-2-oxoethyl]-2-hydroxybutanedioic acid

2-[2-[[4-[[3-Aminopropyl]amino]butyl]amino]-2-oxoethyl]-2-hydroxybutanedioic acid

C13H25N3O6 (319.1743)


   

Hippeastidine

Hippeastidine

C18H25NO4 (319.1783)


   
   
   
   

9-(4-aminophenyl)-7-hydroxy-2,4,6-trimethyl-9-oxonon-2-enoic acid

9-(4-aminophenyl)-7-hydroxy-2,4,6-trimethyl-9-oxonon-2-enoic acid

C18H25NO4 (319.1783)


   

(2S,4S,10R)-4-(3-hydroxy-4-methoxyphenyl)-quinolizidin-2-acetate

(2S,4S,10R)-4-(3-hydroxy-4-methoxyphenyl)-quinolizidin-2-acetate

C18H25NO4 (319.1783)


   

9-(4-aminophenyl)-3,7-O-cyclo-2,4,6-trimethyl-9-oxo-nonanoic acid

9-(4-aminophenyl)-3,7-O-cyclo-2,4,6-trimethyl-9-oxo-nonanoic acid

C18H25NO4 (319.1783)


   
   
   
   
   
   
   
   
   
   
   
   

chloroquine

chloroquine

C18H26ClN3 (319.1815)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   
   
   
   
   
   
   

NA 18:6;O3

N-(nonanoyl)-2,3-(Z)-dehydrotyrosine

C18H25NO4 (319.1783)


   

1-[(tert-butyl)oxycarbonyl]-3-benzylpiperidine-3-carboxylic acid

1-[(tert-butyl)oxycarbonyl]-3-benzylpiperidine-3-carboxylic acid

C18H25NO4 (319.1783)


   

n-boc-4-benzyl-4-piperidinecarboxylic acid

n-boc-4-benzyl-4-piperidinecarboxylic acid

C18H25NO4 (319.1783)


   

TERT-BUTYL 2-(4-(METHOXYCARBONYL)-2-METHYLPHENYL)PYRROLIDINE-1-CARBOXYLATE

TERT-BUTYL 2-(4-(METHOXYCARBONYL)-2-METHYLPHENYL)PYRROLIDINE-1-CARBOXYLATE

C18H25NO4 (319.1783)


   

4-BENZYL-1-(TERT-BUTOXYCARBONYL)PIPERIDINE-4-CARBOXYLIC ACID

4-BENZYL-1-(TERT-BUTOXYCARBONYL)PIPERIDINE-4-CARBOXYLIC ACID

C18H25NO4 (319.1783)


   

BOC-(4-METHYLBENZYL)-DL-PRO-OH

BOC-(4-METHYLBENZYL)-DL-PRO-OH

C18H25NO4 (319.1783)


   
   

Ethyl 1-Cbz-3-ethylpiperidine-3-carboxylate

Ethyl 1-Cbz-3-ethylpiperidine-3-carboxylate

C18H25NO4 (319.1783)


   

1-Benzyl 3-methyl 3-isopropyl-1,3-piperidinedicarboxylate

1-Benzyl 3-methyl 3-isopropyl-1,3-piperidinedicarboxylate

C18H25NO4 (319.1783)


   

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-ETHYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-ETHYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C18H25NO4 (319.1783)


   

TERT-BUTYL 4-HYDROXYSPIRO[CHROMAN-2,4-PIPERIDINE]-1-CARBOXYLATE

TERT-BUTYL 4-HYDROXYSPIRO[CHROMAN-2,4-PIPERIDINE]-1-CARBOXYLATE

C18H25NO4 (319.1783)


   

tert-butyl 4-(4-formylbenzyloxy)piperidine-1-carboxylate

tert-butyl 4-(4-formylbenzyloxy)piperidine-1-carboxylate

C18H25NO4 (319.1783)


   

ethyl (E,2S)-2-(tert-butoxycarbonylamino)-5-phenyl-pent-3-enoate

ethyl (E,2S)-2-(tert-butoxycarbonylamino)-5-phenyl-pent-3-enoate

C18H25NO4 (319.1783)


   

BENZYL N-BOC-4-PIPERIDINECARBOXYLATE

BENZYL N-BOC-4-PIPERIDINECARBOXYLATE

C18H25NO4 (319.1783)


   

n-boc-(s)-cyclopropylalanine benzyl ester

n-boc-(s)-cyclopropylalanine benzyl ester

C18H25NO4 (319.1783)


   

1,3-Piperidinedicarboxylic acid, 3-(phenylmethyl)-, 1-(1,1-dimethylethyl) ester, (3R)-

1,3-Piperidinedicarboxylic acid, 3-(phenylmethyl)-, 1-(1,1-dimethylethyl) ester, (3R)-

C18H25NO4 (319.1783)


   

N-CBZ-2-PIPERIDINECARBOXYLIC ACID T-BUTYL ESTER

N-CBZ-2-PIPERIDINECARBOXYLIC ACID T-BUTYL ESTER

C18H25NO4 (319.1783)


   

4-CARBOXYMETHYL-4-PHENYL-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-CARBOXYMETHYL-4-PHENYL-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C18H25NO4 (319.1783)


   

Tesmilifene hydrochloride

Tesmilifene hydrochloride

C19H26ClNO (319.1703)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C210 - Immunoadjuvant > C2141 - Chemo Immunostimulant Adjuvant C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent C2140 - Adjuvant

   

(+)-Chloroquine

(+)-Chloroquine

C18H26ClN3 (319.1815)


   

(R)-chloroquine

(R)-chloroquine

C18H26ClN3 (319.1815)


   

N-citryl-spermidine

N-citryl-spermidine

C13H25N3O6 (319.1743)


   

Leu-Thr-Ser

Leu-Thr-Ser

C13H25N3O6 (319.1743)


A tripeptide composed of L-leucine, L-threonine and L-serine joined in sequence by peptide linkages.

   

N-[2-(1-cyclohexenyl)ethyl]-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

N-[2-(1-cyclohexenyl)ethyl]-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

C19H21N5 (319.1797)


   

glycyl-L-leucyl-L-methioninamide cation

glycyl-L-leucyl-L-methioninamide cation

C13H27N4O3S+ (319.1804)


   

(3Z)-3-[(2E,4E,6E)-1-hydroxydodeca-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione

(3Z)-3-[(2E,4E,6E)-1-hydroxydodeca-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione

C18H25NO4 (319.1783)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(3R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxynonanoate

(3R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxynonanoate

C15H27O7- (319.1757)


   

(3R,8R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxynonanoate

(3R,8R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxynonanoate

C15H27O7- (319.1757)


   

N-(2-Propenoxybenzylidene)bis(trimethylsilyl)methylamine

N-(2-Propenoxybenzylidene)bis(trimethylsilyl)methylamine

C17H29NOSi2 (319.1788)


   

bhas#10(1-)

bhas#10(1-)

C15H27O7 (319.1757)


Conjugate base of bhas#10

   

bhos#10(1-)

bhos#10(1-)

C15H27O7 (319.1757)


Conjugate base of bhos#10

   

pyranonigrin I

pyranonigrin I

C18H25NO4 (319.1783)


A member of the class of pyrrolidin-2-ones with formula C18H25NO4, originally isolated from Aspergillus niger.

   

(4e)-7-(chloromethylidene)-n-(2-phenylethyl)dec-4-enimidic acid

(4e)-7-(chloromethylidene)-n-(2-phenylethyl)dec-4-enimidic acid

C19H26ClNO (319.1703)


   

(2e)-9-(4-aminophenyl)-7-hydroxy-2,4,6-trimethyl-9-oxonon-2-enoic acid

(2e)-9-(4-aminophenyl)-7-hydroxy-2,4,6-trimethyl-9-oxonon-2-enoic acid

C18H25NO4 (319.1783)


   

2-ethyl-1-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}cyclopropane-1-carboxylic acid

2-ethyl-1-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}cyclopropane-1-carboxylic acid

C18H25NO4 (319.1783)


   

(1s,2s)-1-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-2-ethylcyclopropane-1-carboxylic acid

(1s,2s)-1-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-2-ethylcyclopropane-1-carboxylic acid

C18H25NO4 (319.1783)


   

4-(3-hydroxy-4-methoxyphenyl)-octahydro-1h-quinolizin-2-yl acetate

4-(3-hydroxy-4-methoxyphenyl)-octahydro-1h-quinolizin-2-yl acetate

C18H25NO4 (319.1783)


   

(2s,4s,9ar)-4-(3-hydroxy-4-methoxyphenyl)-octahydro-1h-quinolizin-2-yl acetate

(2s,4s,9ar)-4-(3-hydroxy-4-methoxyphenyl)-octahydro-1h-quinolizin-2-yl acetate

C18H25NO4 (319.1783)


   

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-(3-methoxyphenyl)propanoate

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-(3-methoxyphenyl)propanoate

C18H25NO4 (319.1783)


   

( )-chloroquine

( )-chloroquine

C18H26ClN3 (319.1815)


   

7-(chloromethylidene)-n-(2-phenylethyl)dec-4-enimidic acid

7-(chloromethylidene)-n-(2-phenylethyl)dec-4-enimidic acid

C19H26ClNO (319.1703)


   

[(7s,7ar)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2e)-2-methylbut-2-enoate

[(7s,7ar)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2e)-2-methylbut-2-enoate

C18H25NO4 (319.1783)


   

[(7r,7as)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 3-methylbut-2-enoate

[(7r,7as)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 3-methylbut-2-enoate

C18H25NO4 (319.1783)


   

2-[(2s,3r,5r,6s)-6-[2-(4-aminophenyl)-2-oxoethyl]-3,5-dimethyloxan-2-yl]propanoic acid

2-[(2s,3r,5r,6s)-6-[2-(4-aminophenyl)-2-oxoethyl]-3,5-dimethyloxan-2-yl]propanoic acid

C18H25NO4 (319.1783)


   

(2e,4s,6s,7r)-9-(4-aminophenyl)-7-hydroxy-2,4,6-trimethyl-9-oxonon-2-enoic acid

(2e,4s,6s,7r)-9-(4-aminophenyl)-7-hydroxy-2,4,6-trimethyl-9-oxonon-2-enoic acid

C18H25NO4 (319.1783)


   

2-[(1-hydroxynonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

2-[(1-hydroxynonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C18H25NO4 (319.1783)


   

(2z)-2-[(1-hydroxynonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

(2z)-2-[(1-hydroxynonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C18H25NO4 (319.1783)


   

(4e,7e)-7-(chloromethylidene)-n-(2-phenylethyl)dec-4-enimidic acid

(4e,7e)-7-(chloromethylidene)-n-(2-phenylethyl)dec-4-enimidic acid

C19H26ClNO (319.1703)


   

4-methoxy-3-methyl-5-[(4e)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-4-ylidene]furan-2-one

4-methoxy-3-methyl-5-[(4e)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-4-ylidene]furan-2-one

C18H25NO4 (319.1783)


   

4-methoxy-3-methyl-5-[(1s,2r,3s,4e,6r)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-4-ylidene]furan-2-one

4-methoxy-3-methyl-5-[(1s,2r,3s,4e,6r)-3-methyl-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-4-ylidene]furan-2-one

C18H25NO4 (319.1783)


   

2-{6-[2-(4-aminophenyl)-2-oxoethyl]-3,5-dimethyloxan-2-yl}propanoic acid

2-{6-[2-(4-aminophenyl)-2-oxoethyl]-3,5-dimethyloxan-2-yl}propanoic acid

C18H25NO4 (319.1783)


   

(2e)-4-[(1s,3r,4s,7s)-4-hexyl-6-hydroxy-2-oxa-6-azatricyclo[5.3.0.0¹,³]dec-8-en-10-ylidene]but-2-enoic acid

(2e)-4-[(1s,3r,4s,7s)-4-hexyl-6-hydroxy-2-oxa-6-azatricyclo[5.3.0.0¹,³]dec-8-en-10-ylidene]but-2-enoic acid

C18H25NO4 (319.1783)